- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.
Total 421 results
-
Jazz PharmaceuticalsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPain | Advanced CancerUnited States, Germany, United Kingdom, Mexico, Poland, Romania, Bulgaria, Czechia, Hungary, Puerto Rico
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingGeneralized Anxiety DisorderUnited States, Spain, Japan, Bulgaria, Sweden, Finland, Estonia, Slovakia
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAutosomal Recessive Polycystic Kidney (ARPKD)United States, United Kingdom, Belgium, Poland, France, Germany, Italy
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Belgium, Canada, Chile, Colombia, Croatia, Hungary, Mexico, Netherlands, Slovakia, Slovenia, Spain, Ireland
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Bulgaria, Denmark, Estonia, Greece, Poland, Portugal, Puerto Rico, United Kingdom, Germany, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, Romania, Russian Federation, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedSchizophreniaUnited States, Serbia, Ukraine, Croatia, Colombia, Russian Federation, Bulgaria, Latvia
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, Serbia, Croatia, Bulgaria, Latvia, Russian Federation, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...Enrolling by invitationImmunoglobulin A NephropathyUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeSpain, United States, Italy, United Kingdom, Hungary, France, Poland, Australia, Bulgaria, Czechia, South Africa
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPost Traumatic Stress DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Estonia, Germany, Poland, Portugal, Puerto Rico
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBorderline Personality DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Terminated
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTuberculosis, Pulmonary | Extensively Drug-Resistant Tuberculosis | Tuberculosis, Multidrug ResistantKorea, Republic of, China, United States, Egypt, Estonia, Japan, Latvia, Peru, Philippines
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedTuberculosisLatvia, Lithuania
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTuberculosis, Multidrug-ResistantKorea, Republic of, China, Estonia, Latvia, Peru, Philippines
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Australia, Bulgaria, Romania, India, Slovakia, Philippines
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney Disease (ADPKD)United States, Australia, Belgium, Germany, Italy, Poland, Romania, United Kingdom, Argentina, Canada, France, Netherlands, Russian Federation
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity Disorder | Attention Deficit DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultidrug Resistant TuberculosisPhilippines, South Africa
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPolycystic Kidney, Autosomal DominantBelgium, Germany, Italy, Spain, Sweden, United States, Canada, Australia, Netherlands, Czechia, Poland, Denmark, Israel, Hungary, Russian Federation, South Africa, United Kingdom, Romania, Argentina, Norway
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedSchizophrenia | Major Depressive Disorder | Bipolar 1 DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney DiseaseUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedNervous System Diseases | Schizophrenia | Mental DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedChronic Kidney Disease | Autosomal Dominant Polycystic Kidney DiseaseAustralia, Belgium, Italy, Spain, Sweden, United States, Canada, Netherlands, Czechia, Poland, Germany, Russian Federation, Hungary, Israel, Puerto Rico, Argentina, Denmark, South Africa, United Kingdom, Norway, France, Romania
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, MajorUnited States, Poland, Serbia, Russian Federation, Germany, Canada, France
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPediatric | Multidrug Resistant TuberculosisPhilippines, South Africa
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedAdolescent Schizophrenia | Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic FeaturesIndia, United States, Bulgaria, Croatia, Hungary, Malaysia, Philippines, Poland, Romania, Russian Federation, Serbia, Taiwan, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, Croatia, Serbia, Bulgaria, India, Korea, Republic of, Philippines, Romania, Russian Federation, Slovakia, Taiwan, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Terminated
-
Otsuka Pharmaceutical Development & Commercialization...WithdrawnNervous System Diseases | Schizophrenia | Mental Disorder | Bipolar 1 DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, India, Malaysia, Philippines, Romania, Russian Federation, Taiwan
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedHyponatremia | Inappropriate ADH Syndrome | Dilutional HyponatremiaUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAdvanced CancerUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBipolar DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedUlcerative ColitisUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedCongestive Heart FailureUnited States, Canada, Netherlands, United Kingdom, France, Spain, Germany, Switzerland, Italy, Brazil, Argentina, Russian Federation, Belgium, Romania, Czech Republic, Norway, Poland, Sweden